Detalhe da pesquisa
1.
Correction: Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles.
RSC Adv;
14(25): 17945, 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38841391
2.
Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles.
RSC Adv;
14(24): 16713-16726, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38784419
3.
Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers.
RSC Adv;
13(45): 31908-31924, 2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37915441
4.
Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer.
RSC Adv;
13(40): 27722-27737, 2023 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37736568
5.
Novel quinoxaline-based VEGFR-2 inhibitors to halt angiogenesis.
Bioorg Chem;
139: 106735, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37531818
6.
Potential role of PIM1 inhibition in the treatment of SARS-CoV-2 infection.
J Genet Eng Biotechnol;
21(1): 65, 2023 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37211584
7.
Review on fluorinated nucleoside/non-nucleoside FDA-approved antiviral drugs.
RSC Adv;
12(48): 31032-31045, 2022 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36348998
8.
Development of fluorinated nicotinonitriles and fused candidates as antimicrobial, antibiofilm, and enzyme inhibitors.
Arch Pharm (Weinheim);
355(7): e2200040, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411641
9.
Exploration of Nitroaromatic Antibiotics via Sanger's Reagent: Synthesis, In Silico, and Antimicrobial Evaluation.
ACS Omega;
7(6): 5254-5263, 2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35187340
10.
Synthesis of new arylazopyrazoles as apoptosis inducers: Candidates to inhibit proliferation of MCF-7 cells.
Arch Pharm (Weinheim);
354(1): e2000214, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32924168
11.
Synthesis, Molecular Modeling of Novel Substituted Pyridazinones and their Vasorelaxant Activities.
Med Chem;
17(2): 171-186, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32216740
12.
Design and synthesis of novel tranilast analogs: Docking, antiproliferative evaluation and in-silico screening of TGFßR1 inhibitors.
Bioorg Chem;
105: 104368, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33091671
13.
New cyanopyridine-based scaffold as PIM-1 inhibitors and apoptotic inducers: Synthesis and SARs study.
Bioorg Chem;
105: 104378, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33099167
14.
Corrigendum to "Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase/topoisomerase IV inhibition" [Bioorg. Chem. 94 (2020) 103437].
Bioorg Chem;
98: 103716, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32200325
15.
Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase/topoisomerase IV inhibition.
Bioorg Chem;
94: 103437, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31812260
16.
Apoptosis: A target for anticancer therapy with novel cyanopyridines.
Bioorg Chem;
94: 103481, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31837830
17.
Novel 1,3,4-Triaryl Pyrazoles: Synthesis, QSAR Studies and Cytotoxicity against Breast Cancer.
Anticancer Agents Med Chem;
19(7): 948-959, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30727920
18.
Biological Validation of Novel Polysubstituted Pyrazole Candidates with in Vitro Anticancer Activities.
Molecules;
21(3): 271, 2016 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26927048
19.
Synthesis and docking studies of novel benzopyran-2-ones with anticancer activity.
Eur J Med Chem;
45(9): 3950-9, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20580139
20.
New quinoxaline 1, 4-di-N-oxides: anticancer and hypoxia-selective therapeutic agents.
Eur J Med Chem;
45(7): 2733-8, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20236735